Skin care

UK's Premier Hair and Skin Clinic, Este Medical Group, Expands Its Expertise to Dubai in April 2024

Retrieved on: 
Thursday, March 14, 2024
Skin care, Patient, Follicular unit extraction, FUE

Dubai, United Arab Emirates--(Newsfile Corp. - March 14, 2024) - Este Medical Group, renowned in the UK for its state-of-the-art hair and skin treatments, is thrilled to announce the grand opening of its new branch in Dubai, UAE, in April 2024.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - March 14, 2024) - Este Medical Group, renowned in the UK for its state-of-the-art hair and skin treatments, is thrilled to announce the grand opening of its new branch in Dubai, UAE, in April 2024.
  • Este Medical Group has established itself as a leader in the field of cosmetic and medical treatments, offering innovative solutions for hair transplantation, skin care, and anti-aging treatments.
  • The opening of the Dubai branch is part of Este Medical Group's mission to make world-class hair and skin treatments more accessible.
  • "We are excited to bring Este Medical Group's renowned treatments and services to Dubai," said Sam Cinkir, CEO of Este Medical Group.

Mblue Labs Discovers Anti-Aging Power In Methylene Blue, Launches Bluelene Face&Neck Remodel Mask

Retrieved on: 
Wednesday, March 13, 2024
Scientific Reports, Health, Skin care, ECM, Face, Retinol, Radical (chemistry), Cell nucleus, Peptide, Extracellular matrix, DNA, Research, ROS, Mitochondrion, Methylene blue, Skin, Collagen, DNA repair, UMD, Identity matrix, Human, Ageing, Neck, Cosmetics

Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.

Key Points: 
  • Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.
  • Mblue Labs, a woman and minority-owned business, is dedicated to advancing skincare science, and this latest product embodies their commitment to unparalleled innovation.
  • Methylene Blue penetrates skin cells at the mitochondrial level, creating cell health and proliferation.
  • To view an enhanced version of this graphic, please visit:
    The Face & Neck Remodel Mask features a powerful blend of the latest age-reversal ingredients, including Methylene Blue, Growth Factors, Advanced Peptides, and Niacinamide.

Bestqool Launches Innovative Red Light Therapy Devices for Eczema Relief

Retrieved on: 
Friday, April 5, 2024
Skin care, Fibroblast, Health, Certification, RLT, Psoriasis, Adenosine triphosphate, Cell, Serotonin, Patient, Photobiology, Tissue, Rosacea, Mitochondrion, Mental health, History, Red, Quality of life, Dermatitis, Itch, Keratinocyte, Acne, Skin, Pollution, Erythema, Cytokine, Irritation, ATP, Immune system, Recurrence, Fatigue, Swelling, FDA, Waste, Medical device

Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.

Key Points: 
  • Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.
  • Combining red light therapy with topical ointments can be a complementary approach for effective eczema treatment.
  • Bestqool's latest range of portable red light therapy devices are designed to be both convenient and effective for home use.
  • Adding red light therapy to daily care and prevention can repair both inside and outside by lowering eczema recurrence and improving the quality of life.

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024
Skin care, Research, Lung cancer, Ovarian cancer, DP, Head, Conference, Face, Cell, Skin cancer, Immunotherapy, TIL, Clinical, Cancer, Cervical cancer, HNSCC, George Washington University, Patient, Gene, American Academy, D&O, IND, Centricity, AACR, Glioblastoma, Skin, Breast cancer, Scalp, Melanoma, Patent, SITC, Private law, FDA, BRD4, Food, Pharmaceutical industry

MARLBOROUGH, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the year ended December 31, 2023 and provided a business update.

Key Points: 
  • The latter clearance was significant since there are no drugs specifically approved to treat early stages I and II of cSCC.
  • As of February, the first two patients in our first cohort have completed treatment with PH-762 with no reported adverse events.
  • In 2023 we implemented a cost rationalization program driven by our transition from discovery research to product development.
  • At December 31, 2023 we had cash of $8.5 million as compared with $11.8 million at December 31, 2022.

New Zealand Mānuka Honey: Science Confirms Genetic Uniqueness And Urges Informed Choices For Consumers

Retrieved on: 
Thursday, March 28, 2024
Honey, Skin care, Unique, UMF, Research, DNA, News, Common, Plant & Food Research, Plant, Immune system, AgResearch, Tree, Leptospermum

This news empowers consumers to make informed choices when seeking genuine mānuka honey with its renowned antibacterial, anti-inflammatory, and antioxidant properties.

Key Points: 
  • This news empowers consumers to make informed choices when seeking genuine mānuka honey with its renowned antibacterial, anti-inflammatory, and antioxidant properties.
  • The Unique Mānuka Factor Honey Association (UMFHA), the trusted leader in mānuka honey quality and authentication, applauds the clarity for consumers of these latest findings.
  • The findings confirmed that mānuka trees from New Zealand and Tasmania (Australia) are genetically distinct enough to be considered separate species.
  • "Consumers choosing mānuka honey for its health benefits need accurate information to select the ideal product," says Tony Wright, CEO of the UMFHA.

Waldencast Class Action Investigation: Johnson Fistel, LLP is Investigating for Violation of Securities Laws; WALD, WALDW

Retrieved on: 
Thursday, March 21, 2024
Skin care, WALD, SAN, Bank statement, LLP

The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Key Points: 
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
  • Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program.

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws (WALD, WALDW)

Retrieved on: 
Tuesday, March 19, 2024
Skin care, WALD, SAN, Bank statement, LLP

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Key Points: 
  • SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.

Korea Cosmetics (K-Beauty) Market Analysis Report 2024-2029: Brands are Losing Out in the Chinese Market to Local Players in the Mass Segment and to Global Players in the Premium Segment - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 4, 2024
Cosmetics, Retail, Delivery Services, Olive, Skin care, Growth, Olive Young, Beauty, COVID-19, Internet, Research, ODM, Female, DIY, Sale, Social media, Woman, City, Supermarket, OEM, Skin, Traction, Market, Government, Production

The Korea cosmetics market value stood at US$6.57 billion in 2023, and is expected to reach US$9.05 billion by 2029.

Key Points: 
  • The Korea cosmetics market value stood at US$6.57 billion in 2023, and is expected to reach US$9.05 billion by 2029.
  • Geographically, the market is not limited to a specific region within Korea but has a significant presence throughout the country.
  • Korean brands are losing out in the Chinese market to local brands in the mass segment and to global players in the premium segment, leading to inevitable and painful restructuring.
  • The report provides the bifurcation of the Korea cosmetics market into two segments based on category, premium products and mass products.

Global Skin Toner Market Analysis Report, 2023-2024 and 2029 - Surging Trend of Diversity and Inclusivity and Accelerating Popularity of Online Shopping and E-Commerce Platforms - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Cosmetics, Online Retail, Retail, Skin care, Nicotinamide, COVID-19, Pimple, Research, Female, Dermatology, Woman, Supermarket, Acne, Skin, Mist, Habit, Market, Salicylic acid

The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.

Key Points: 
  • The global skin toners market was valued at US$1.31 billion in 2023 and is expected to reach US$1.73 billion by 2029.
  • The global skin toners market is extremely competitive and consists of various global and regional players.
  • Looking ahead, the skin toners market is expected to continue its growth trajectory for several reasons.
  • One notable aspect of the skin toners market is the growing awareness regarding skincare and protection among the millennial population, across the world, in the recent years.

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

Retrieved on: 
Thursday, March 21, 2024
Class Action Lawsuit, Professional Services, Legal, Skin care, WALD, Bank statement, LLP

Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Key Points: 
  • Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • What if I purchased Waldencast securities?
  • If you purchased securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.